GlassScriptPhysician profile
Amanda D Parton
NPI 1245476183
$7,010.35
in general payments reported to CMS, 2019-2025
31 companies · $2,550 in 2025
The $2,550 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $945 · 2022: $903 · 2023: $938 · 2024: $1,675 · 2025: $2,550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,050 · Travel and Lodging: $1,077 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,049.80 |
| Travel and Lodging | $1,077.32 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,637.51 | 2021-2025 | Cardiomems, Esprit, Xact |
| E.R. Squibb & Sons, L.L.C. | $684.13 | 2021-2025 | Camzyos, Eliquis |
| Amgen INC. | $482.33 | 2022-2024 | Repatha |
| Merck Sharp & Dohme LLC | $473.49 | 2021-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $276.09 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $272.16 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $230.41 | 2023-2025 | Enroute Transcarotid Neuroprotection System, Bodyguardian, Watchman Flx |
| Kowa Pharmaceuticals America, INC. | $181.37 | 2021-2022 | |
| Endologix LLC | $173.05 | 2025 | Torus Stent Graft System, Endocross Device |
| Astrazeneca Pharmaceuticals LP | $172.27 | 2021-2023 | Farxiga |
| Medtronic, INC. | $157.74 | 2025 | Endurant Iis |
| Bolton Medical INC | $156.70 | 2024 | Treo Abdominal Stent-Graft System |
| Novo Nordisk INC | $153.42 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $143.91 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $139.59 | 2023-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $131.22 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.88 | 2021-2023 | Jardiance |
| Irhythm Technologies, INC. | $51.33 | 2024 | Zio Xt Patch, Zio Monitor |
| Nevro Corp. | $48.02 | 2024 | Senza |
| Atricure, INC. | $47.25 | 2022-2024 | |
| Insulet Corporation | $47.09 | 2024 | Omnipod |
| Medicure Pharma INC. | $35.49 | 2024 | Zypitamag |
| Lexicon Pharmaceuticals, INC. | $35.00 | 2024 | Inpefa |
| Esperion Therapeutics, INC. | $25.16 | 2021 | |
| Cvrx, INC. | $24.19 | 2024 | Barostim Neo System |
| Corcept Therapeutics | $23.23 | 2025 | Korlym |
| Kestra Medical Technology Services, INC. | $21.59 | 2023 | Assure Wcd |
| Cashflow Solutions, LLC | $20.96 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Kiniksa Pharmaceuticals International, Plc | $20.28 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $20.13 | 2022 | |
| Inspire Medical Systems, INC. | $18.36 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Parton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.